Showing 5041-5050 of 10638 results for "".
Severe Allergic Reactions: The Potential Detriments of Diphenhydramine
https://reachmd.com/programs/clinicians-roundtable/severe-allergic-reactions-the-potential-detriments-of-diphenhydramine/18011/What does the data show for the use of oral and intramuscular diphenhydramine? Tune in to find out.Encouraging CPR Participation from Bystanders
https://reachmd.com/programs/clinicians-roundtable/encouraging-cpr-participation-from-bystanders/2927/In cases of out-of-hospital sudden cardiac arrest, bystanders are now formally encouraged to bypass full cardiopulmonary resuscitation (CPR), in favor of continuous chest compressions. This instruction comes following a March 2008 scientific advisory published in the journal Circulation. GivenThe Corticosteroid Journey in PMR: Understanding the Patient Experience
https://reachmd.com/programs/medical-industry-feature/pmr-corticosteroid-patient-experience/39774/Even though corticosteroids can bring quick, symptomatic relief for patients with polymyalgia rheumatica (PMR), their long-term use may be associated with adverse consequences.1-3 But adopting an individualized strategy and exploring alternative therapies can help empower patients to actively engageInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
https://reachmd.com/programs/maps-chats/medical-affairs-msl-ai-strategy-impact/56814/Today’s medical science liaisons (MSLs) are navigating a rapidly shifting healthcare landscape. Step inside the evolving world of medical affairs as Dr. Matt Birnholz sits down with Dr. Brandon Young, senior MSL at CSL Seqirus, to uncover how communication, collaboration, and emerging technologies aNavigating Vaccine Communication: A Medical Affairs Perspective
https://reachmd.com/programs/maps-chats/vaccine-communication-medical-affairs/56810/At the intersection of expertise, strategy, and collaboration, medical affairs professionals are translating vaccine science into meaningful and actionable insights for healthcare providers. In this candid conversation from the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, Dr. MatEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
https://reachmd.com/programs/neurofrontiers/emerging-technologies-in-ms-neuromodulation-and-myelin-regeneration/32702/Explore how neuromodulation could play a role in restoring myelin loss in patients with multiple sclerosis.Developments in Duchenne Muscular Dystrophy Care: Examining the Options
https://reachmd.com/programs/neurofrontiers/developments-in-duchenne-muscular-dystrophy-care-examining-the-options/32357/Advancements in gene therapies have expanded the treatment landscape for Duchenne muscular dystrophy. Read about the benefits and drawbacks of each approach.SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
https://reachmd.com/programs/project-oncology/sabcs-2023-a-look-into-new-research-for-inflammatory-breast-cancer/16287/Dive into recent research for inflammatory breast cancer that was presented at the 2023 San Antonio Breast Cancer Symposium.The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
https://reachmd.com/programs/FDA-Drug-Information-Updates/fdas-adverse-event-reporting-system-faers-public-dashboard/9864/Dr. Janet Woodcock, Director of the FDA Center for Drug Evaluation and Research, discusses the new FAERS Dashboard's strengths and limitations.Genomic Medicine's Emergence in Primary Care
https://reachmd.com/programs/genetically-speaking/genomic-medicines-emergence-primary-care/7308/Incorporating family histories and genetic health information into primary care has been a long term vision for many experts in the medical genetics field. When will this vision become a reality, and what will it take to enable widespread adoption of these tools in general practioners' offices natio